Найти книгу: "Medicine at a Glance"

The central title in the market-leading at a Glance series, Medicine at a Glance provides a concise and accessible introduction to the study of medicine and is the ultimate revision guide for the core medical curriculum. Ideal for medical students, Foundation Programme doctors and those training in the allied health professions, Medicine at a Glance presents each topic as clear, double-page spreads with key facts accompanied by tables, illustrations, photographs and diagrams. Used by thousands of students in its previous two editions, Medicine at a Glance has been fully revised and updated to ensure that it remains THE essential revision guide purchase Contains new chapters on history and examination, patient consent and confidentiality, and substance abuse Further coverage of the essential facts for the diagnosis and treatment of common symptoms and conditions Offers full support for PBL-style courses via self-assessment cases and MCQs contained in a brand new case-based book, Medicine at a Glance: Core Cases which is also available online at: www.ataglanceseries.com/medicine For more information on the complete range of Wiley-Blackwell medical student and junior doctor publishing, please visit: www.wileymedicaleducation.com Reviews of previous editions «Fantastic revision tool before finals with all the breadth of information you need and full colour, clearly laid out diagrams.» —Medical Student, St. Georges Medical School «The most up-to-date and best presented clinical medicine text on the market. It contains succinct and clear explanations of the medical conditions any student is expected to know. A student favourite.» —Medical Student, Nottingham University «I definitely recommend this book to all final year students....» —Final Year Student, GKT «…once you start using this book, you won't say goodbye to it…» —Gube Magazine, Melbourne University Medical Students Association

Futurological forecast. What is a post-industrial civilization. Nanotechnologies. Nanomedicine. Immortality. Already now for 3 million dollars it is possible to buy cyber immortality.

A novel about transforming organizations from the author of bestselling business books The Goal and Zapp! The Cure is a novel for managers about transforming an under-performing bureaucratic organization into a boundaryless, fact-driven management culture like the one that made Jack Welch's General Electric so consistently successful. It offers real, practical advice for overcoming political inertia, reinventing the company, and doing it in a year or less. By giving each key character a distinct voice, readers are reminded of people they have met and who may even sit in the desk next to them. These characters interact realistically and act pragmatically, and as a result readers become invested in how these people tackle their challenges and create real solutions. The methods described in the book have been successfully employed at many of high-profile companies, such as Black & Decker, Coleman, Emerson, Parker Hannifin, Textron, United Stationers, and Moen. The Cure argues that modern organizations must be flexible, quick, and boundaryless in order to thrive and survive, but it also shows managers how to make it happen fast. Based on the successful management theories of Dan Paul's General Management Technologies, The Cure accomplishes these things in the form of an entertaining, enlightening, and dramatic business narrative. Jeff Cox (Murrysville, PA) is a creative writer known for weaving progressive business concepts into compelling fiction. He is the coauthor of such business bestsellers as The Goal, Zapp!, and Heroz. Dan Paul (Pittsburgh, PA) is CEO of General Management Technologies, a consulting practice which focuses on the alignment of clients' strategies, work processes, and culture in order to target all the functions of a business on the same priorities. Formerly with General Electric, he's worked with many high-profile clients and spoken at many conferences on strategic management for Business Week and the American Management Association.

A behind-the-scenes look at the most lucrative discipline within biotechnology Bioinformatics represents a new area of opportunity for investors and industry participants. Companies are spending billions on the potentially lucrative products that will come from bioinformatics. This book looks at what companies like Merck, Glaxo SmithKline Beecham, and Celera, and hospitals are doing to maneuver themselves to leadership positions in this area. Filled with in-depth insights and surprising revelations, Digital Code of Life examines the personalities who have brought bioinformatics to life and explores the commercial applications and investment opportunities of the most lucrative discipline within genomics. Glyn Moody (London, UK) has published numerous articles in Wired magazine. He is the author of the critically acclaimed book Rebel Code.